Tesamorelin 10mg

With FREE BAC Water

COAs available upon request

Tesamorelin

Overview

Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) developed to selectively stimulate the release of endogenous growth hormone through activation of GHRH receptors in the anterior pituitary. Engineered with structural modifications that improve stability while maintaining receptor specificity, Tesamorelin has become an important research peptide in studies involving endocrine regulation, metabolism, and body composition.

Used exclusively for laboratory and research applications, Tesamorelin continues to be investigated in experimental models examining growth hormone physiology, lipid metabolism, and cellular signalling pathways associated with metabolic function.

Research Applications

Preclinical and experimental studies have investigated Tesamorelin across several key areas of scientific interest:

Growth Hormone Secretion
Researchers study Tesamorelin for its ability to stimulate pulsatile secretion of endogenous growth hormone, providing a valuable model for investigating GHRH receptor activation and endocrine regulation.

Metabolic Physiology
Experimental models have explored the peptide's influence on lipid metabolism, glucose homeostasis, and energy utilisation, making it an important research tool in metabolic biology.

Body Composition Research
Laboratory investigations continue to evaluate Tesamorelin in studies examining fat metabolism, lean tissue maintenance, and physiological processes associated with body composition.

Endocrine Signalling
Tesamorelin allows researchers to investigate the relationship between growth hormone, insulin-like growth factor-1 (IGF-1), and downstream metabolic pathways involved in nutrient utilisation and tissue regulation.

These characteristics have established Tesamorelin as a valuable research compound for laboratories studying GHRH biology, endocrine signalling, and metabolic physiology.

Technical Specifications

• Chemical Name: Tesamorelin Acetate
• Alternative Names: TH9507; Egrifta® (research reference)
• Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
• Molecular Weight: Approximately 5135.9 g/mol
• Amino Acid Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Ser-NH₂
• CAS Number: 218949-48-5
• Peptide Classification: Synthetic Growth Hormone-Releasing Hormone (GHRH) analogue

Storage Recommendations

• Lyophilized Tesamorelin remains stable at room temperature during short-term handling.
• For long-term storage, keep the peptide at −20 °C or below.
• Following reconstitution, refrigerate between 2 °C and 8 °C. Stability after reconstitution will depend on the solvent used and storage conditions.

Solubility

Tesamorelin is generally soluble in sterile water, bacteriostatic water, and compatible aqueous buffer solutions, depending on formulation and purity.

References

Thorner, M. O., Strasburger, C. J., Wu, Z., et al. (1996). Growth hormone-releasing hormone analogue therapy and stimulation of endogenous growth hormone secretion. Journal of Clinical Endocrinology & Metabolism.

Falutz, J., Allas, S., Blot, K., et al. (2007). Metabolic effects of a growth hormone-releasing factor analogue in HIV-infected patients with abdominal fat accumulation. New England Journal of Medicine, 357(23), 2359–2370.

Stanley, T. L., & Grinspoon, S. K. (2015). Effects of growth hormone-releasing hormone analogues on metabolism and body composition. Nature Reviews Endocrinology, 11(3), 183–194.

Research compound only. Not for human consumption